Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The presynaptic protein α-synuclein is central to the pathogenesis of α-synucleinopathies. We show that the presence of endogenous mouse α-synuclein leads to higher number of dopaminergic neurons in the substantia nigra of wild-type C57Bl/6J mice compared with C57Bl/6S mice with a spontaneous deletion of the α-synuclein gene or C57Bl/6J mice with a targeted deletion of the α-synuclein gene. This effect of α-synuclein on dopaminergic neuron occurs during development between E10.5 and E13.5 and persists in adult life supporting the involvement of α-synuclein in the development of a subset of dopaminergic neurons.

Original publication

DOI

10.1016/j.expneurol.2013.07.015

Type

Journal article

Journal

Exp Neurol

Publication Date

10/2013

Volume

248

Pages

541 - 545

Keywords

Dopaminergic, Embryonic development, Parkinson's disease, Transgenic mouse, α-Synuclein, Animals, Cell Count, Dopaminergic Neurons, Mice, Mice, Inbred C57BL, Mice, Knockout, Substantia Nigra, alpha-Synuclein